Genenta Science S.p.A. American Depositary Shares

GNTA XNAS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

52M

Short interest (May 15)

0.0%

Net Short (Jun 03 ): 0.2%

Borrow Fee

49.92%

↑ 53.9%

Available Shares

↓ 99.4%

Price Chart

Company Overview

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Company Info

Exchange: NASDAQ

CIK: 0001838716

Asset Type: ADRC

Market Data

Market Cap: $51,900,244

Employees: 9

Status: Active

Short Interest

Current Borrow Fee 49.92%

Range: 49.92% - 49.92%

Available Shares 0

Range: 0 - 0

Recent Changes

Fee Change: ↓ 0.0%

Available Change: ↓ 100.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime